0
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Platelet-Derived Growth Factor Does Not Induce c-fos in NIH 3T3 Cells Expressing the EJ-ras Oncogene

, &
Pages 5052-5055 | Received 22 Feb 1988, Accepted 08 Aug 1988, Published online: 31 Mar 2023

Literature Cited

  • Armelin, H. A., M. C. S. Armelin, K. Kelly, T. Stewart, P. Leder, B. H. Cochran, and C. D. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (London) 310:655-660.
  • Benjamin, C. W., W. G. Tarpley, and R. R. Gorman. 1987. Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH 3T3 cells expressing the EJ-ras oncogene. Proc. Natl. Acad. Sci. USA 84:546-550.
  • Benjamin, C. W., W. G. Tarpley, and R. R. Gorman. 1987. The lack of PDGF-stimulated PGE2 release from ras-transformed NIH 3T3 cells results from reduced phospholipase C but not phospholipase A2 activity. Biochem. Biophys. Res. Commun. 145:1254-1259.
  • Berridge, M. J., and R. F. Irvine. 1984. Inositol trisphosphate— a novel second messenger in cellular signal transduction. Nature (London) 312:315-321.
  • Bos, J. L., D. Toksoz, C. J. Marshall, M. Verlaan-DeVries, G. H. Veeneman, A. J. VanderEb, J. H. vanBoom, J. W. G. Janssen, and A. C. M. Steenvoorden. 1985. Amino-aciil substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukemia. Nature (London) 315:726-730.
  • Bravo, R., M. Neuberg, J. Burckhardt, J. Almendral, R. Wallich, and R. Muller. 1987. Involvement of common and cell type-specific pathways in c-fos gene control: stable induction by cAMP in macrophages. Cell 48:251-260.
  • Chirgwin, J. M., A. E. Przybyla, R. J. McDonald, and W. J. Rutter. 1979. Isolation of biochemically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
  • Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
  • Colletta, G., A. M. Cirafici, E. Consiglio, and G. Vecchio. 1987. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras transformed rat thyroid cell line. Oncogene Res. 4:459-466.
  • Coughlin, S. R., W. M. F. Lee, P. W. Williams, G. M. Giels, and L. T. Williams. 1985. c-myc expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell 43:243-251.
  • Der, C. J., and G. M. Cooper. 1983. Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas. Cell 32:201-208.
  • Der, C. J., T. G. Krontiris, and G. M. Cooper. 1982. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc. Natl. Acad. Sci. USA 79:3637-3640.
  • Ek, B., B. Westermark, A. Wasteson, and C. H. Heldin. 1983. Stimulation of tyrosine specific phosphorylation by platelet- derived growth factor. Nature (London) 195:419-420.
  • Ellis, R. W., D. DeFes, T. Y. Shih, M. A. Gonda, H. A. Young, N. Tsuchida, D. R. Lowry, and E. M. Scolnick. 1981. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (London) 292:506-511.
  • Erickson, J. M., C. L. Rushford, G. N. Wilson, and R. D. Schmickel. 1981. Structure and variation of human ribosomal DNA: molecular analysis of cloned fragments. Gene 16:1-9.
  • Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
  • Feramisco, J. R., M. Gross, T. Kamata, M. Rosenberg, and R. W. Sweet. 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:109-117.
  • Finkel, T., C. J. Der, and G. M. Cooper. 1984. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21. Cell 37:151-158.
  • Gibbs, J. B., I. S. Sigal, M. Poe, and E. M. Scolnick. 1984. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc. Natl. Acad. Sci. USA 81:5704-5708.
  • Glisin, V., R. Crkvenjakov, and C. Byus. 1974. Ribonucleic acid isolation by cesium chloride centrifugation. Biochemistry. 13:2633-2637.
  • Guerrero, I., A. Pellicer, and D. E. Burstein. 1988. Dissociation of c-fos from ODC expression and neuronal differentiation in a PC12 subline stably transfected with an inducible N-ras oncogene. Biochem. Biophys. Res. Commun. 150:1185-1192.
  • Hall, A., C. J. Marshall, N. K. Spurr, and R. A. Weiss. 1983. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (London) 303:396-400.
  • Hurley, J. B., M. E. Simon, D. B. Teplow, J. D. Robinshaw, and A. D. Gilman. 1984. Homologies between signal transducing G proteins and ras gene products. Science 226:860-862.
  • Kruger, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature (London) 312:711-716.
  • McCoy, M. S., J. J. Toole, J. M. Cunningham, E. H. Chang, D. R. Lowry, and R. A. Weinberg. 1983. Characterization of a human colon/lung carcinoma oncogene. Nature (London) 302:79-81.
  • McGrath, J. P., D. J. Capon, P. V. Goeddel, and A. D. Levinson. 1984. Comparative biochemical properties of normal and activated human ras p21 protein. Nature (London) 310:644-649.
  • Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras protooncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (London) 313:241-243.
  • Muller, R., R. Bravo, J. Burckhardt, and T. Curran. 1984. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (London) 312:716-620.
  • Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature (London) 308:693-698.
  • Parada, L. F., C. J. Tabin, C. Shih, and R. A. Weinberg. 1982. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (London) 297:474-478.
  • Rains, E. W., and R. Ross. 1982. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J. Biol. Chem. 257:5154-5160.
  • Rosengurt, E. 1986. Early signals in the mitogenic response. Science 234:161-166.
  • Ruther, V., E. F. Wagner, and R. Muller. 1985. Analysis of the differentiation potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J. 4:1775-1781.
  • Santos, E., S. R. Tronick. S. A. Aaronson, S. Pulciani, and M. Barbacid. 1982. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (London) 298:343-347.
  • Stacey, D. W., and H. F. Kung. 1984. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature (London) 310:508-511.
  • Stacey, D. W., T. Watson, H. F. Kung, and T. Curran. 1987. Microinjection of transforming ras protein induces c-fos expression. Mol. Cell. Biol. 7:523-527.
  • Sweet, R. W., S. Yokoyama, T. Kamata, J. R. Feramisco, M. Rosenberg, and M. Gross. 1984. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (London) 311:273-275.
  • Taparowsky, E., K. Shimizu, M. Goldfarb, and M. Wigler. 1983. Structure and activation of the human N-ras gene. Cell 34:581-586.
  • Tarpley, W. G., N. K. Hopkins, and R. R. Gorman. 1986. Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene. Proc. Natl. Acad. Sci. USA 83:3703-3707.
  • Ullrich, A., J. Shine, J. Chirgwin, R. Pictet, E. Tischer, W. J. Rutler, and H. M. Goodman. 1977. Rat insulin genes: construction of plasmids containing the coding sequences. Science 196:1313-1319.
  • Yuasa, Y., S. K. Srivastava, C. Y. Dunn, J. S. Rhim, E. P. Reddy, and S. A. Aaronson. 1983. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature (London) 303:775-779.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.